NO165195C - Analogifremgangsmaate for fremstilling av terapeutisk aktive nye derivater av 4,5-dihydro-oksazolyl-2-((2-pyridyl)-metyl-tio- eller metylsulfinyl)-benz- eller tienoimidazoler. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive nye derivater av 4,5-dihydro-oksazolyl-2-((2-pyridyl)-metyl-tio- eller metylsulfinyl)-benz- eller tienoimidazoler.

Info

Publication number
NO165195C
NO165195C NO873722A NO873722A NO165195C NO 165195 C NO165195 C NO 165195C NO 873722 A NO873722 A NO 873722A NO 873722 A NO873722 A NO 873722A NO 165195 C NO165195 C NO 165195C
Authority
NO
Norway
Prior art keywords
preparation
tienoidid
oxsazolyl
methylsulphinyl
benz
Prior art date
Application number
NO873722A
Other languages
English (en)
Norwegian (no)
Other versions
NO873722L (no
NO165195B (no
NO873722D0 (no
Inventor
Dieter Binder
Franz Rovenszky
Hubert Peter Ferber
Original Assignee
Chemie Linz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemie Linz Ag filed Critical Chemie Linz Ag
Publication of NO873722D0 publication Critical patent/NO873722D0/no
Publication of NO873722L publication Critical patent/NO873722L/no
Publication of NO165195B publication Critical patent/NO165195B/no
Publication of NO165195C publication Critical patent/NO165195C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
NO873722A 1986-09-10 1987-09-07 Analogifremgangsmaate for fremstilling av terapeutisk aktive nye derivater av 4,5-dihydro-oksazolyl-2-((2-pyridyl)-metyl-tio- eller metylsulfinyl)-benz- eller tienoimidazoler. NO165195C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT243786 1986-09-10

Publications (4)

Publication Number Publication Date
NO873722D0 NO873722D0 (no) 1987-09-07
NO873722L NO873722L (no) 1988-03-11
NO165195B NO165195B (no) 1990-10-01
NO165195C true NO165195C (no) 1991-01-09

Family

ID=3534337

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873722A NO165195C (no) 1986-09-10 1987-09-07 Analogifremgangsmaate for fremstilling av terapeutisk aktive nye derivater av 4,5-dihydro-oksazolyl-2-((2-pyridyl)-metyl-tio- eller metylsulfinyl)-benz- eller tienoimidazoler.

Country Status (21)

Country Link
US (1) US4818760A (xx)
EP (1) EP0261478B1 (xx)
JP (1) JPS6377878A (xx)
KR (1) KR880003941A (xx)
AT (1) ATE62908T1 (xx)
AU (1) AU596869B2 (xx)
CA (1) CA1256109A (xx)
CS (1) CS268191B2 (xx)
DD (1) DD262230A5 (xx)
DE (1) DE3769563D1 (xx)
DK (1) DK165322C (xx)
ES (1) ES2028838T3 (xx)
FI (1) FI89267C (xx)
GR (1) GR3001842T3 (xx)
HU (1) HU198059B (xx)
MY (1) MY102003A (xx)
NO (1) NO165195C (xx)
NZ (1) NZ221723A (xx)
SG (1) SG39892G (xx)
SU (1) SU1574177A3 (xx)
ZA (1) ZA876740B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0983263A1 (en) * 1997-05-30 2000-03-08 Dr. Reddy's Research Foundation Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
CN1361683A (zh) 1999-06-07 2002-07-31 比克·古尔顿·劳姆贝尔格化学公司 含有一种对酸不稳定的活性化合物的新型制剂和药物剂型
CA2493618A1 (en) * 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
US8802139B2 (en) * 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
PL1746980T3 (pl) * 2004-05-07 2012-03-30 Nycomed Gmbh Farmaceutyczna postać dawkowania zawierająca peletki i sposób jej wytwarzania
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
WO2007112581A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4045564A (en) * 1974-02-18 1977-08-30 Ab Hassle Benzimidazole derivatives useful as gastric acid secretion inhibitors
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
GB8305245D0 (en) * 1983-02-25 1983-03-30 Fujisawa Pharmaceutical Co Imidazo-heterocyclic compounds
SE8404065D0 (sv) * 1984-08-10 1984-08-10 Haessle Ab Novel biologically active compounds
FI861772A (fi) * 1985-05-07 1986-11-08 Chemie Linz Ag Nya tieno(2,3-d)imidazolderivat och foerfarande for deras framstaellning.
DE3777855D1 (de) * 1986-02-20 1992-05-07 Hoechst Ag Substituierte thienoimidazol-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer.

Also Published As

Publication number Publication date
KR880003941A (ko) 1988-05-31
ZA876740B (en) 1988-03-14
NO873722L (no) 1988-03-11
SU1574177A3 (ru) 1990-06-23
NO165195B (no) 1990-10-01
DK165322C (da) 1993-03-29
FI873892A0 (fi) 1987-09-09
DD262230A5 (de) 1988-11-23
FI873892A (fi) 1988-03-11
NZ221723A (en) 1989-11-28
CS649787A2 (en) 1989-05-12
AU596869B2 (en) 1990-05-17
HUT47288A (en) 1989-02-28
SG39892G (en) 1992-10-02
ES2028838T3 (es) 1992-07-16
DK469687A (da) 1988-03-11
ATE62908T1 (de) 1991-05-15
DK469687D0 (da) 1987-09-09
JPS6377878A (ja) 1988-04-08
DE3769563D1 (de) 1991-05-29
CS268191B2 (en) 1990-03-14
FI89267B (fi) 1993-05-31
HU198059B (en) 1989-07-28
EP0261478A1 (de) 1988-03-30
US4818760A (en) 1989-04-04
DK165322B (da) 1992-11-09
GR3001842T3 (en) 1992-11-23
CA1256109A (en) 1989-06-20
FI89267C (fi) 1993-09-10
EP0261478B1 (de) 1991-04-24
MY102003A (en) 1992-02-29
NO873722D0 (no) 1987-09-07
AU7817087A (en) 1988-03-17

Similar Documents

Publication Publication Date Title
SE8405754L (sv) 7-karboximetoxi-furo-(3,4-c)-pyridinderivat, framstellning derav och terapeutiska kompositioner innehallande dem
NO165195C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye derivater av 4,5-dihydro-oksazolyl-2-((2-pyridyl)-metyl-tio- eller metylsulfinyl)-benz- eller tienoimidazoler.
ES8706689A1 (es) Procedimiento para la obtencion de nuevos derivados del tieno (2,3-d) imidazol
HU895830D0 (en) Process for the preparation of 1,2,3,4-tetrahydro-1,9-acridine-diamines and pharmaceutical compositions containing said compounds
MA21026A1 (fr) Derives de 4-(aroylamino) piperidinebutanamide, et leur procede de preparation
AU658175B2 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
AU579295B2 (en) New thiazole derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
AU2994589A (en) Novel basic-substituted 5-halo-thienoisothiazol-3-(2h)-one-1,1-dioxides, process for the preparation thereof, and pharmaceutical preparations containing these compounds
ES2001893A6 (es) Procedimiento para la obtencion de derivados de metilendioxifenantreno
IL88124A (en) Pharmaceutical compositions containing 2-isoxazoline and isoxazole-5-yl phosphonate derivatives, process for their preparation and some novel compounds
NO823676L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-furyl-3,4-dihydroisokinolin-derivater
TH2131B (th) การเตรียมอนุพันธ์ของเบนซิมิดาโซลและสารผสมของสารเหล่านี้